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Preface 
This thesis is submitted for the degree Philosophiae Doctor (PhD) at the University of 
Bergen. The work has been carried out at the Department of Chemistry and the Centre 
for Pharmacy at the University of Bergen, at the School for Chemical Sciences and 
Pharmacy at the University of East Anglia, Norwich, UK and at the Antenatal Clinic 
and Antenatal Ultrasound Department at the Norfolk and Norwich University 
Hospital, Norwich, UK. The thesis consists of five papers. 
The aim of the work was to study use of herbal remedies during pregnancy. It was the 
intention to: 
• Describe the users. 
• Identify the types of herbs used and the extent of use. 
• Identify the indications for use. 
• Identify the sources of information about herbs used by the women. 
• Review the literature on safety and efficacy of the herbs used. 
• Gain a better understanding of women’s reasons for use of herbs – their 
attitudes and feelings. 
 
Chapter 1 gives an introduction to the topics herbal products, their use in pregnancy, 
pregnancy as such and pharmacoepidemiology. Chapter 2 presents the methods used, 
Chapter 3 the main results, Chapter 4 a general discussion of the results and Chapter 5 
conclusions and future perspectives. 
All plants will be mentioned by their English name in the text but a table of English, 
Norwegian and Latin names of mentioned plants is given below. Plants only 
mentioned in Appendix B are not included. Latin names according to Barnes et al1 
except from those marked A or B. A refers to Heinrich et al2 and B to Blumenthal3. 
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Table 1 Names of plants discussed in this thesis 
Latin English Norwegian 
Arctostaphylos uva-ursi (L.) Spreng. Bearberry Melbær 
Carum carvi L. A Caraway Karve 
Matricaria recutita L. or 
Chamaemelum nobile (L.) All. 
Chamomile Kamille  
Vaccinium macrocarpon Aiton Cranberry Tranebær 
Taraxacum officinale Weber  Dandelion Løvetann 
Echinacea purpurea (L.) Moench 
Echinacea pallida (Nutt.) Nutt. 
Echinacea angustifolia DC. 
Echinacea 
Coneflower 
Solhatt  
Foeniculum vulgare P. Mill.A Fennel Fennikel  
Frangula alnus Mill. Frangula Trollhegg 
Zingiber officinale Roscoe Ginger Ingefær 
Panax ginseng C.A. Meyer Ginseng Ginseng 
Aesculus hippocastanum L. Horse chestnut Hestekastanje 
Equisetum arvense L.B Horsetail Kjerringrokk 
Åkersnelle 
Melissa officinalis L. Lemon balm Sitronmelisse 
Mentha x piperita L. A Peppermint Peppermynte  
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Rubus idaeus L. Raspberry Bringebær 
Senna alexandrina L. Senna Sennes 
Hypericum perforatum L. St. John’s wort Prikkperikum, 
Johannesurt 
Valeriana officinalis L. Valerian Valeriane  
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Abstract 
Background: The use of herbal remedies is gaining popularity in the western world 
though little scientific documentation for safety and efficacy is available. Women are 
found to be more frequent users of herbs than men and studies from North America, 
Australia and Europe have shown widespread use among pregnant women. 
 
Objective: The major aim of the work was to study use of herbal remedies during 
pregnancy in two different populations and by different methods. 
 
Methods: One study was performed as a survey among 578 pregnant women at the 
Norfolk and Norwich University Hospital between November 2007 and February 
2008. Use of herbal remedies and treatment of various ailments were studied. Six 
women from this study population also participated in a focus group discussion about 
the results of the survey and their reasons for herb use in pregnancy. Another study 
was performed in the Swedish Medical Birth Register. Data on the use of herbal 
remedies during pregnancy were obtained from 860215 pregnant women during the 
period 1st July 1995 to end of 2004. Outcome variables studied were prematurity, 
birth weight, Apgar score, number of infants in delivery and congenital 
malformations. 
 
Results: The usage of herbal remedies during pregnancy was 57.8% in the UK study 
and 0.9% in the Swedish study. This very big difference is probably mainly due to the 
different methods of data collection. Ginger, cranberry and raspberry leaf were the 
most commonly used herbal remedies in the UK study while Floradix®, ginseng and 
valerian were most commonly reported in the Swedish study. 
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Family and friends were the most used source of information about herbs used in 
pregnancy in the UK study and 75% of the herb users did not inform their doctor or 
midwife about the herb use. Potentially harmful herbs or herbs for which the 
documentation for safety in pregnancy is inadequate were used by 41.2% of the 
participants. Forty one different herbs were reported used and 96 different indications 
were given for the use but 46 of those indications could not be confirmed in literature 
as “traditional use”.  
The focus group discussion showed that users of herbal remedies expected health care 
personnel to disapprove of herb use and thus did not reveal use to them.  They found 
it difficult to find a reputable alternative practitioner but they wanted the National 
Health Services to include alternative therapists in the public healthcare system. 
 
Conclusion: Use of herbal remedies is common among pregnant women while 
documentation of safety and efficacy is limited. Health care personnel should be able 
to give evidence based information about herbs but more research is necessary to 
enable this. 
 
Future perspectives: Studies are necessary to document as well safety as efficacy of 
herbs during pregnancy. Controlled clinical trials are preferred but will probably be 
difficult for practical as well as economical and ethical reasons so prospective 
observational studies regarding herbal remedy usage and pregnancy outcome are 
warranted to determine safety. Communication of scientific data about herbal safety 
to the public is a challenge because it is a general belief that herbs are safer than 
pharmaceuticals. Though some women acknowledge that some herbs may have side 
effects, they still believe that the herbs they use are safe. Another challenge for the 
future is to introduce more education about herbal remedies in the training of health 
care personnel. As this education needs to be evidence based, this challenge is linked 
to the need for more research in the field. 
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Abbreviations 
ATC Anatomical Therapeutical Chemical (classification system for drugs) 
BMI Body mass index 
CAM Complementary and alternative medicine 
CI Confidence interval 
CNS Central nervous system 
EMEA European Medicines Evaluation Agency  
EU European Union 
INR International normalized ratio 
LGA Large for gestation age 
MA Marketing authorisation 
NHS National Health Services 
NMA Norwegian Medicines Agency 
NVP Nausea and vomiting in pregnancy 
OR Odds ration 
OTC Over the counter 
SGA Small for gestation age 
SPC Summary of product characteristics 
UTI Urinary tract infections 
WHO World Health Organisation 
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1. Introduction 
1.1 Herbal remedies – regulations, safety and efficacy 
The use of herbal remedies is increasing worldwide and has been for years4. In 1996, 
the British Medical Journal published the news “Complementary medicine is 
booming worldwide”5. Women are found to be more frequent users of herbs than 
men5,6. A population based survey from England in 1998 found that 20% of 2669 
adults had used OTC herbal remedies during the last 12 months and that 31% had 
used them sometime during their lifetime while only 1% had visited a medical 
herbalist during the last 12 months and 4% sometime during their lifetime7.  It is a 
common misunderstanding that herbs are natural and thus safe and this may lead 
people to use herbs instead of pharmaceuticals8,9. This is especially appealing to 
pregnant women who are concerned about not only their own health but also the 
health of their unborn baby.  
 
1.1.1 The regulation of herbal products in Norway and in the EU 
Manufacturers of pharmaceuticals must apply for a “Marketing Authorisation” (MA) 
for their products before they can bring them to the market. In this process 
documentation for the quality, safety and efficacy of the product is evaluated by either 
the national authorities in one EU country (in Norway: The Norwegian Medicines 
Agency, NMA) or by the European Medicines Evaluation Agency (EMEA). In 
addition the product information aimed at health care professionals (the Summary of 
Product Characteristics, SPC) and consumers (package inserts) are approved. 
Regulation of herbal products is different. Until recently there has been no common 
regulation in the EU. The NMA has had an “Herbal medicines” (“Naturlegemidler”) 
scheme since 1995. The application procedure has been simpler than for 
pharmaceuticals – equal for quality documentation but no requirement of 
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toxicological, pharmacological and clinical documentation  (safety and efficacy) if 
“the product was intended for self treatment of conditions which the user could 
diagnose and treat without medical supervision” and if “the applicant could refer to 
scientific publications regarding the contents of the product and their traditional use 
in Europe and/or North America for at least 30 years, it has a well known effect and is 
acceptably safe”. If the symptoms could be caused by a serious condition, the product 
label or insert should state that the user should seek medical advice to rule out this 
before taking the product. The NMA had the right to give directives with respect to 
label and insert.  
In 2005 the EU directive 2001/83/EC as amended in 2004/24/EC was intended to be 
implemented in all EU countries. Work on developing monographs for herbal 
ingredients is ongoing in the EU and in Norway the new regulations will enter into 
force from 30.4.2011. All products with a MA according to the established 
regulations will need a new MA to remain on the market. In the new regulations, two 
different procedures will be available for herbal medicines:”Well-established herbal 
medicinal products” and “Traditional herbal medicinal products”. For both categories 
the necessary quality documentation is similar to that for pharmaceuticals. For the 
well-established herbal medicinal products the safety and efficacy can be documented 
in the same way as for those pharmaceuticals where MA is sought based on 
bibliographic documentation based on well established use. For traditional herbal 
medicinal products safety and efficacy can be made probable from all of the 4 points 
below: 
1. Medicinal use for at least 30 years, whereof at least 15 in the EU. 
2. A bibliographic review of all available safety documentation and an expert 
report on this. 
3. Indication suitable for self-treatment. 
4. For oral, topical or inhalation use. 
If an EU monograph for the herb is available or if the herb is on the EU list, this and 
an expert report stating that the EU documentation is valid for the relevant product is 
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accepted as documentation. The intentions of the directive are to acquire better safety 
for the consumers, to give easier access to traditional herbal products of a documented 
quality, to ascertain that safety and indications are based on long experience and to 
give a full declaration, a package insert and an SPC. 
 
In Norway as well as in the EU many products are legally sold without a MA. They 
can be sold as “Food supplements” as long as they don’t contain herbs regulated as 
“medicinal” according to “Lov om legemidler” (Act relating to medicines). In 
Norway they are regulated by “Lov om matproduksjon og mattrygghet mm” (Act 
relating to food production and food safety. etc.). In that case no documentation of 
quality, safety or efficacy is reviewed before the product is marketed. The only 
request is a notification. In addition there are regulations for the labelling and 
advertising. It is illegal to claim that a food supplement can “prevent or treat disease, 
symptoms thereof or pain” and that “a balanced and varied food intake gives 
insufficient amounts of vitamins and minerals”. A committee, “Syse-utvalget”, was 
appointed to give recommendations on legal or illegal claims about food 
supplements10. The committee established a list of claims and decided whether they 
are “medicinal claims” which are only to be used about pharmaceuticals, “legal health 
claims” which can be used about food supplements or “illegal health claims” which 
can not be used at all. The list is supposed to show examples and new claims must be 
evaluated according to that. 
 
Herbal practitioners and other alternative practitioners mix and sell herbs to their 
clients. In medical herbalism it is common to use a mixture of herbs, made up for the 
individual patient. As long as the herbs are not listed as “medicinal” according to 
“Lov om legemidler” this is also legal and unregulated. 
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In conclusion it is possible to sell herbal products without applying for a MA and thus 
without the products being evaluated for quality, safety and efficacy.  
 
1.1.2 Quality issues 
The lack of quality control of food supplements (see 1.1.1) represents a potential risk 
to the users. Mistaking one plant for another, microbial disintegration or 
contamination of plant material and deliberate forgery are actual problems. One case 
of contamination of a herbal “internal cleansing cure” with Digitalis lanata was 
described in 1998. The product was said to contain “plantain” (Plantago sp.) but the 
raw material was contaminated from the supplier and caused heart symptoms in a 
patient11. Contamination of Chinese herbal medicines with aristolochic acid is well 
known12,13. This leads to nephropathy (commonly known as “Chinese herb 
nephropathy”) and often to life-long treatment with dialysis. More than 100 women 
were affected by this in Belgium in the 1990es as they used a slimming treatment. The 
latest development is “Herbal Viagra” or herbal aphrodisiacs shown to contain 
analogues of sildenafil (active constituent of Viagra®) or other similar substances14.  
 
1.1.3 Pharmacovigilance 
Associated with a MA for a pharmaceutical is a demand for pharmacovigilance. 
Pharmacovigilance has been defined by the World Health Organisation (WHO) as 
“the science and activities relating to the detection, assessment, understanding and 
prevention of adverse effects or any other possible drug-related problems” 15. As well 
the manufacturer as the authorities collect and analyse reports of side effects. The aim 
of this is to identify risks and risk factors in the shortest possible time and in this way 
also identify previously unsuspected adverse effects or adverse effects in special 
patient groups (pregnant women, children, elderly) where clinical trials are often not 
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performed before the MA is granted. This information, if used effectively, allows for 
evidence-based use of medicines.  
In many countries like Norway and the UK reporting of adverse effects is 
spontaneous. It has commonly been done by health care personnel (doctors, dentist 
and pharmacists) but lately some schemes, like the UK Yellow Card Scheme16, have 
opened for reports from patients. The spontaneous reporting schemes are also open 
for reports on adverse effects of herbal remedies but the Norwegian authorities state 
in their annual report from 2007 that this group of adverse effects is underreported17. 
An explanation for this is suggested by Barnes who describes the situation from a UK 
point of view18. Herbal remedies are often recommended by family and friends or by 
the popular media and they are bought OTC from a pharmacy, from a herbal shop or 
on the Internet18. Professional advice is not commonly sought and herb use is often 
not disclosed to health care personnel18. For this reason adverse effects are not 
disclosed either and are thus not reported18. The new EU legislation on ”Well-
established herbal medicinal products” and “Traditional herbal medicinal products” 
will require manufacturers to comply with provisions of pharmacovigilance.  
 
1.1.4  Safety of selected herbs in pregnancy 
Safety data for herbal remedies used in pregnancy is mainly based on experience over 
time as few clinical trials are performed so the evidence base is minimal. Herbs 
commonly used in pregnancy and for which some clinical documentation is available 
include: Ginger, cranberry, raspberry leaf, echinacea and St. Johns wort. When 
choosing herbs for use during pregnancy one should always evaluate the need against 
the risk.  
 
 1.1.4.1 Ginger  
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Ginger is probably the herb most studied in pregnant women. It has been used 
traditionally to treat nausea for centuries. Nine clinical trials and one prospective 
study were found (see Appendix A)19-28. The doses tested in the clinical trials were 
between 0.5 g and 1.5 g a day for 3 – 21 days19-22,24-28 except from one study giving 6 
g a day for 4 days23. No adverse effects on pregnancy outcome were reported, but the 
studies were small (14 – 146 women in the treatment group) and thus might not reveal 
uncommon effects.  
It has been hypothesised that ginger can influence testosterone metabolism in the 
foetus29 but no clinical or experimental data to suggest or contradict this concern were 
found30. Some concern has been expressed about the mutagenicity of gingerol but a 
study from 1987 found that while gingerol was mutagenic in a test on Salmonella 
typhimurium zingerone suppressed the mutagenic activity31.  
Interestingly however GraviFrisk® (translates to something like “PregnaWell” and 
equating to a daily dose  of 6g of dried ground ginger) which was advertised for 
pregnant women in Denmark was withdrawn from the market in February 2008 due to 
fear of effect on the metabolism of testosterone in the foetus and thus on the 
development32.  The Danish Veterinary and Food Administration stated that it is not 
dangerous to consume food containing ginger, but that the amount in different herbal 
products is too high32.   
A sound conclusion seems to be that ginger can be used in amounts not greatly 
exceeding the amounts used in food or drink. 
 
 1.1.4.2 Cranberry 
One study  of multiple daily doses of cranberry showed no difference between the 
treatment and control groups with regard to obstetric or neonatal outcomes (see 
Appendix A)33. Another study has shown that patients at risk for nephrolithiasis 
(whether pregnant or not) should not take concentrated cranberry products 
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(tablets/capsules)34. If cranberry is used to treat urinary tract infections (UTI) it might 
not be effective (see 1.1.5.2). Twenty to 30 % of untreated cases of UTI are expected 
to lead to acute pyelonephritis. This may result in low birth weight, premature 
delivery, and, occasionally, stillbirth35,36. For this reason it is important that UTI 
during pregnancy are treated with antibiotics.  
It seems sensible to conclude that cranberry can be used in amounts not greatly 
exceeding the amounts used in food or drink but is not recommended as sole 
treatment for UTI. 
 
 1.1.4.3. Raspberry leaf 
One double blind, randomised, controlled trial and one retrospective study of 
raspberry leaf was found (see Appendix A)37,38. The dose tested in the controlled trial 
was 2 x 1.2 g a day, from 32 weeks until labour. No adverse effects were seen but the 
study was small with only 96 women in the test group. Doses varied between one and 
eight cups of tea/tablets a day in the retrospective study. Duration of use varied 
between 1 and 32 weeks and started as early as week 8. No adverse effects were seen. 
No firm conclusions can be drawn on this basis and thus raspberry leaf should not be 
used during pregnancy until further documentation is available. 
 
 1.1.4.4 Echinacea 
No clinical trials were found on the safety of echinacea during pregnancy but one 
prospective study was available (see Appendix A)39. The doses varied: Tablets 250 – 
1000 mg a day, tincture 5 – 30 drops a day. The duration was 5 – 7 days. The 
treatment group consisted of 206 women. No significant differences in spontaneous 
abortions or malformations were seen between treatment and control groups.  
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No firm conclusions can be drawn on this basis and thus echinacea should not be used 
during pregnancy until further documentation is available. 
 
 1.1.4.5 St John’s wort 
No clinical trials were found on the safety of St. John’s wort during pregnancy. One 
single case report40 was found (see Appendix A). Two cases are mentioned but only 
one is followed through delivery and one month after. No unwanted effects were 
described. 
Due to the lack of safety data, St. John’s wort should not be used during pregnancy. 
 
1.1.5 Efficacy of selected herbs used in pregnancy 
Efficacy data for herbal remedies used during pregnancy is mainly based on use over 
time and on a few clinical trials and prospective studies just like the safety 
documentation.  
 
 1.1.5.1 Ginger 
Two clinical trials of 1 g ginger daily and one of 6 g found ginger more effective 
against nausea than placebo, two trials comparing 1 resp. 1.5 g ginger to Vitamin B6 
found the products equally useful, two trials comparing 1 resp. 2 g ginger to Vitamin 
B6 found ginger more effective and one study of 1 g ginger found that ginger may be 
useful in some pregnant women. One trial comparing ginger to dimenhydrinate found 
the products equally effective. A prospective study with various doses found that 
ginger capsules were better than other ginger forms but that almost half of the women 
found ginger totally ineffective (see Appendix A)19-28. 
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 1.1.5.2 Cranberry 
The use of cranberry juice or tablets/capsules to prevent recurrent UTI gets some 
support from a Cochrane review41. The conclusion is that there is some evidence that 
cranberry juice may decrease the number of symptomatic UTI over a 12 month period 
but that a large number of dropouts/withdrawals indicate that cranberry juice may not 
be acceptable over long periods of time. Neither optimum dose nor preferred method 
of administration is clear. Conversely another Cochrane review considering cranberry 
for treatment of UTI concludes that there is no good quality evidence to support that it 
is effective42. One pilot study of the preventive effect of cranberry juice against 
asymptomatic bacteriuria in pregnancy concludes that the results suggest that there 
may be a protective effect, but the data did not show statistical significance (see 
Appendix A)33.  
 
 1.1.5.3 Raspberry leaf 
One study showed that raspberry leaf did not shorten the first stage of labour, but the 
second stage with 9.59 min38. A lower rate of forceps deliveries was also seen38. The 
retrospective study showed some effect on shortening and less “mechanical 
assistance”37. None of the described differences between treatment- and control group 
were statistically significant37,38. 
 
 1.1.5.4 Echinacea 
Efficacy of echinacea has not been studied during pregnancy. A Cochrane review of 
publications on the efficacy in prevention and treatment of common cold with 
echinacea has found that no studies show preventive effect better than placebo but 
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that there is some evidence that preparations based on Echinacea purpurea might be 
effective for the early treatment of colds in adults43. 
 
 1.1.5.5 St. John’s wort 
Efficacy of St. Johns wort has not been studied during pregnancy. A Cochrane review 
of 29 publications on the efficacy of St. Johns wort on major depression shows that 
the herb is superior to placebo, similarly effective to standard antidepressants and 
causes fewer side effects but that studies from German-speaking countries come to 
more positive conclusions than others44.   
 
1.1.6 Risk of interactions between the above mentioned herbs and various 
pharmaceuticals 
Herbs contain a complex mixture of chemical constituents and can affect 
pharmacokinetic and pharmacodynamic properties of pharmaceuticals45. Various 
herb-drug interactions are described in the literature. Herb-users are often not aware 
of the risk of interactions and do not always inform their doctor about herb use. 
Doctors – even if they are told – do not always have the necessary information or 
knowledge to evaluate the risk of interactions when prescribing drugs to a herb-user46.  
 
 1.1.6.1 Ginger 
 
The most commonly described interaction involving ginger is with warfarin and other 
anticoagulants. Ginger has been found to inhibit tromboxane synthetase and might 
thus cause a prolonged bleeding time47. Theoretically this may add to the effect of 
ingested anticoagulant and thus increase the international normalized ratio (INR). 
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Until more is known, it is recommended to monitor INR closely in patients taking 
significant amounts of ginger48. Ginger may also enhance the effect of CNS 
depressants49. 
 
 
 1.1.6.2 Cranberry 
Contradictory evidence on the effect of cranberry on warfarin is found. Some studies 
show an increase of the international normalized ratio (INR) in patients taking 
cranberry and warfarin simultaneously while other studies show no significant 
effect50,51. The Committee on Safety of Medicine (UK) reported 12 cases in 2004 and 
has concluded that there is sufficient evidence of an interaction for formal advice to 
be issued52. The Committee recommends that patients taking warfarin should avoid 
taking cranberry juice or other cranberry products52. 
 
 1.1.6.3 Raspberry leaf 
Raspberry leaf contains tannins. When iron and tannin containing herbs are taken 
simultaneously, the tannins may interfere with the absorption of the iron and even if 
this is not a serious problem, it should be taken into account in anaemic patients53,54. 
 
 1.1.6.4 Echinacea 
Echinacea is reported to have immunostimulant activity and can therefore 
theoretically decrease the effect of immunosuppressive therapy49. Neff et al describe 2 
patients taking echinacea after a liver transplantation55. Both experienced elevation of 
aminotransferase levels (indication of rejection) which resolved with discontinuation 
of the herb55.  
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 1.1.6.5 St. John’s wort 
 St. John’s wort is found to induce specific CYP450 enzymes and thus have the 
potential to affect the effect of drugs metabolised by those56. Many different drugs 
(ex: cyclosporine, midazolam, amitryptyline, tacrolimus, digoxin, warfarin and 
antidepressants) are mentioned in the literature indicating the importance for doctors 
to ask about herb use and for patients to reveal their use45.  
  
1.1.7 Limited knowledge about herbs among health care personnel 
The knowledge among health care personnel about herbs, their use, toxicity and 
possible interactions with pharmaceuticals is limited. No studies of the knowledge 
about herbal safety in pregnancy were found, but some general studies are available. 
Suchard et al 2004 studied doctors’ knowledge regarding the toxic effects and drug 
interactions of herbal remedies by distributing questionnaires at educational meetings 
of emergency medicine and internal medicine doctors46. A total of 142 questionnaires 
were completed – among those 26 from medical students. The mean subject score on 
the quiz determining the knowledge was only slightly higher than would have been 
from random guessing. The difference was statistically significant but was not 
considered clinically relevant as it equalled less than 4% of the total possible score. 
As many as 74% rated their own knowledge as “poor” and none rated it as “good” or 
“excellent”. Nine percent of the participants had previous formal instruction regarding 
herbal remedies (therapies, toxicities and/or interactions). They all rated their 
knowledge as “fair” but did not get a significantly better quiz score that those rating it 
as “poor”. The authors conclude that “a great deal of education will be necessary”. 
Another study of 1268 doctors, pharmacists, nurses, dieticians and students of those 
professions showed a slightly better result57. The survey was performed prior to the 
participants’ enrolment in an online course about herbal and dietary supplements.  
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The mean score on the knowledge test was 66 %. Doctors, pharmacists and dieticians 
had a significantly higher score than nurses and all categories of students. The study 
also tested “confidence” and “communication”. Users of herbs and dietary 
supplements were more confident than non-users and dieticians and doctors more 
confident than the other groups. Dieticians and doctors were also better at 
communicating information about herbal remedies. The authors conclude that all 
categories of health care personnel would benefit form learning more about herbal 
and dietary supplements and about communication. 
Giveon et al found that 70% of 165 primary care doctors claimed little or no 
knowledge about herbal remedies58. Sixty percent of the 165 doctors expected 10% of 
their patients to use herbal remedies, which is too low an estimate according to the 
authors. 
One study evaluated the effect of a tutorial about uses, contraindications and drug 
interactions of common herbal medicines on the knowledge among doctors59. The 
participants were tested pre- and post-tutorial and showed a statistically significant 
rise in knowledge score from 30% pre-tutorial to 64% post-tutorial. This indicates 
that there is a room for improvement and that it is possible to achieve.  
Nurses do not show better knowledge than doctors. A survey among 149 registered 
nurses about use, purpose, side effects and interactions of ginkgo, St. John’s wort, 
ginseng, garlic and echinacea showed that the nurses neither used nor recommended 
the remedies. They were relatively unfamiliar with the five commonly used herbs and 
more unfamiliar with side effects and interactions than with purpose of use. The 
median number of correctly identified purposes was 28% while for side effects it was 
14% and for interactions only nine percent.  
A study among 164 pharmacists showed similar results; the pharmacists knew more 
about uses of herbal remedies than about possible adverse effects, drug interactions 
and necessary precautions60. The average score on the knowledge test was 42% and 
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pharmacists with previous continuing education or access to information about herbal 
remedies at their practice site had a significantly higher score than those without. 
 
The studies indicate that health care personnel need more knowledge about herbal 
remedies and they are all aware of it. The teaching should preferably be part of their 
basic education and not left to continuing education courses. 
 
1.2 Studies identifying herbal remedy use in pregnancy in the western world 
Studies identifying herb use in pregnancy in the western world are given in Appendix 
B8,61-72. Thirteen studies were identified. Eight were performed in antenatal clinics, 
two in postnatal ward and three in other settings. Seven used self completed 
questionnaires, six were interview studies. The amount of herb users varied between 7 
and 56%. Two studies did not specify amount of herb users but only users of CAM 
(Complementary and Alternative Medicine) where herbs are just a part of this. One 
study showed 96% of herb users but in this study purposeful sampling was used so the 
percentage is not relevant for comparison. 
The most used herb varied between the studies. Raspberry leaf and echinacea were 
the most frequently used herbs in three studies each and ginger in two. Peppermint, 
chamomile, cranberry and St. John’s wort also had more than 10 % users in at least 
one study each and many other herbs were used. Nordeng mentions use of as many as 
46 different herbs70. 
Some authors try to characterise “the most common herb user”. Forster et al from 
Australia describe her as older, tertiary educated, English speaking, non-smoker and 
primiparous72. Other Australian and US authors61,63,67,71 also mention primigravida, 
tertiary education and higher age but Nordeng70 found fewer users than non-users in 
the group of 36 years or older and no other significant differences. The profile of the 
typical user is not well defined. 
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It is a common belief that herbs in general are safer than pharmaceuticals8,9,64,69. They 
are described as not really drugs, milder, more natural, simpler, more familiar or 
having fewer side effects. Hepner et al found that only 14% of the 1203 women 
studied considered herbs to be “medications” and that significantly more women in 
that group discontinued herb use when pregnancy was confirmed63. 
Indications for herb use during pregnancy are described in six studies8,66-68,70,72 and 
they are mainly nausea and vomiting (NVP), labour preparation, cold/flu, sleep/relax, 
urinary tract infections (UTI) and digestion aid. Those are all common ailments in 
pregnancy except from “labour preparation” and some of them can be treated with 
OTC pharmaceuticals. 
 
 The pregnant women took herbal remedies on their own initiative or got 
recommendations and information from various sources like family and friends, 
herbal store, health care personnel, alternative practitioners, books/magazines and the 
internet. Family and friends turned out to be the most important source of information 
and health care personnel were in most cases far less important67,68,70,72. 
 
Different methods have been used and different questions asked. This makes 
comparison between the studies difficult and of limited value. When one study treats 
herbs, other alternative treatments and pharmaceuticals there is a reason to believe 
that the information on each topic is more superficial than if the study treats only one 
aspect of treatment during pregnancy. Thus it would be an advantage if a standardised 
protocol can be used in various countries to compare different cultures and 
populations.  
 
The main concern expressed by the authors is the lack of documentation of safety and 
efficacy of herbal remedies in pregnancy61,62,64,65,67,68,70,72. Another point often 
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mentioned is that health care personnel should identify and monitor use of herbs as 
well as pharmaceuticals and be able to give evidence based advice to pregnant 
women61,63,66,68,70-72. The lack of scientific evidence on many of the used herbs makes 
this a difficult task and the fact that many pregnant women omit telling their health 
care personnel about herb use makes a pro-active attitude necessary. 
 
1.3 Pregnancy 
Pregnancy is timed from the first day of last menstrual period and normally lasts 37-
42 weeks (average 40 weeks). It is split in three trimesters: 1st trimester is week 1 – 
13, 2nd week 14 – 27 and 3rd week 28 – 40. Organogenesis takes place in the first 
trimester making the foetus most sensitive to any compounds ingested by the mother 
in this period73.  
When referring to the condition of a newborn baby, “Apgar score” is commonly used. 
This is a scoring system for heart rate, respiratory effort, muscle tone, reflex 
irritability and colour. Each characteristic is assigned a value of 0 to 2 points so the 
total score is 0 to 10. The newborn is evaluated at 1 and 5 minutes after birth. A score 
of 7 or more is considered normal, 4-6 compromised and 3 or below medical 
emergency74. 
 
1.3.1 Common ailments and treatments 
The numerous physiological changes which occur during pregnancy commonly result 
in a variety of conditions including morning sickness (70%)75, insomnia (66-94%)76, 
heartburn (30-50%)77, constipation (11-38%)78, ankle oedema (12%)79, anaemia (14-
52% in 3rd trimester)80 and urinary tract infection (UTI) by (1 – 13%)81 amongst 
others. Various treatments for most of the ailments are available to the pregnant 
woman. 
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 1.3.1.1 Treatment with pharmaceuticals 
No pharmaceuticals are licensed for use to treat NVP but some products, considered 
to be safe due to experience over time, are used when the condition reaches a certain 
level of severity. First choice when dietary and lifestyle measures have turned out 
insufficient would normally be Vitamin B6. If this also turns out insufficient, 
metoclopramide will be next in line in some countries82 and antihistamines in other 
(Paper I). If metoclopramide fails to relieve the NVP, ondansetrone is 
recommended82. In some cases the NVP develops to hyperemesis gravidarum. If that 
happens, intravenous antiemetics and rehydration therapy will be necessary and in 
severe cases also total parenteral nutrition. 
 
Insomnia can be expected to occur in the 3rd trimester due to hormonal and 
mechanical changes in the body and does not normally need pharmacological 
treatment but rather life style changes with more focus on “sleep-hygiene”76. If 
treatment is necessary, diphenhydramine (an antihistamine) is recommended by 
Briggs83 but contraindicated in 3rd trimester by Schaefer82. 
 
Heartburn can in most cases be relieved with antacids. Aluminium-, calcium- and 
magnesium-containing antacids and sucralfate are considered safe in recommended 
doses and are thus first choice77. If symptoms persist, histamin2-receptor antagonists 
like ranitidine or famotidine can be used according to Richter, Schaefer and 
Briggs77,82,83 though the manufacturers advice to avoid use in pregnancy84.  
 
Constipation is according to a Cochrane review from 2001 best treated with fibre 
supplements78. If they turn out inefficient, a stimulant laxative is preferred according 
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to Jewell78 while Schaefer82 recommends lactulose before stimulant laxatives like 
bisacodyl. The manufacturers describe lactulose as a suitable laxative for pregnant 
women due to minimal absorption. They also state that years of clinical experience 
have shown that neither the pregnancy nor the foetus nor the newborn are influenced 
by the mother’s use of bisacodyl. 
 
Ankle oedema alone should not be treated pharmacologically in pregnancy70. If 
associated with raised blood pressure it can be an indication of pre-eclampsia but 
otherwise it is of no danger but only discomfort85.  
 
Anaemia is commonly and safely treated with iron supplements82. Some women may 
experience gastrointestinal discomfort from Iron(II) salts and might benefit from hem-
iron (haemoglobin bound iron) instead. 
 
UTI are common in pregnancy and should be treated with antibiotics to avoid 
pyelonephritis (see 1.1.4.2). Penicillins are the antibiotics of choice in pregnancy82. 
 
For conditions like NVP and insomnia where dietary or lifestyle changes are 
recommended before pharmaceuticals some women will find it natural to turn to 
herbal remedies. The gastrointestinal discomfort of iron supplements might have the 
same effect as might fear of taking antibiotics and the doctor’s unwillingness to treat 
ankle oedema. 
 
 1.3.1.2 Herbal and other alternative treatments 
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In the treatment of NVP various advices on diet and life style are given by health care 
personnel. The most common are to eat regular, small meals to keep the blood sugar 
level stable, to start the day with dry biscuits and eat them whenever nausea comes or 
to avoid food which triggers nausea. No scientific documentation is available for the 
efficacy of those methods.  The most common herbal remedy is ginger. Ginger is 
tested in nine clinical trials and considered to be safe in the recommended doses, 
better than placebo and just as effective as Vitamin B6 (see 1.1.5.1). It is used in 
different forms like fresh in food or drink, dry for brewing tea or in capsules or as 
biscuits, ale or beer. Ginger is part of the normal diet in many countries, easily 
obtained from the supermarket and as such a simple “first choice”. Peppermint tea 
and chamomile tea are also used but no scientific documentation is available86.  
Other alternative treatments are acupressure and homeopathy. Acupressure is 
commonly performed by use of “sea sickness” bands, which are wrist bands working 
on an acupressure point on the inner wrist but can be performed manually as well87. 
True double-blind trials of acupressure are difficult to perform as a placebo-treatment 
for comparison is difficult to obtain but reviews from 1998 and 2005 concluded that 
evidence for beneficial effects was found and that no harm could be done as 
acupressure points for uterine stimulation are located far from the so called P6 point 
used for relief of NVP30,88. 
Homeopathy is also used but due to the theories of homeopathy, different women 
might need different preparations and self-treatment is thus not easy89. Trials of 
homeopathy are also difficult to perform due to the theories of individual treatments 
so no scientific evidence for the effect is available89. 
 
Common herbal treatments for insomnia are chamomile tea, valerian and lemon balm. 
Scientific documentation of the efficacy or safety of chamomile and lemon balm in 
pregnancy is not available48. Like other composite plants chamomile causes a risk of 
allergic reactions90,91. Two reviews conclude that valerian may improve sleep quality 
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but methodologic flaws of the included studies limit the value of the conclusions92,93. 
The safety of the treatment is inadequately documented (see Paper I).  
Other alternative treatments are relaxation techniques and homeopathy. 
 
Heartburn and indigestion is also often treated with ginger but no scientific 
documentation is available. Other undocumented herbal treatments are chamomile, 
caraway and fennel seeds. 
Other alternative treatments are available, but none are very common. 
 
Constipation is best treated with water and fibre. Herbs like senna and frangula are 
not recommended during pregnancy48 and not commonly used either according to the 
available studies. 
Other alternative treatments are available, but none are very common. 
 
Ankle oedema is commonly treated by rest and elevation of the feet. Diuretic herbs 
like horsetail and dandelion are used by some women and horse chestnut by others. 
No scientific documentation is available about safety or efficacy of horsetail or 
dandelion in pregnancy. Horse chestnut seed has been shown to reduce symptoms of 
chronic venous insufficiency like swelling in the legs94 but no data on safety in 
pregnancy are available. A Cochrane review from 2007 found two small studies 
showing that compression stockings had no effect on ankle oedema but that 
reflexology appeared to help improve symptoms better than rest85. 
 
 35 
The herbal iron supplement Floradix® seems to be well known and used to prevent or 
treat anaemia in Europe70. It is also reported to be recommended by midwives in the 
US95 but no pregnant women have reported use (see Appendix B). Floradix® contains 
20 different herbs and fruit juices at very low levels together with iron and vitamins in 
recommended amounts and consequently it can be used safely in pregnancy96.  
 
Urinary tract infections are sought treated with cranberry, dandelion, horsetail or 
bearberry. Cranberry causes an anti-adherence effect on the bladder mucosa making it 
difficult for the bacteria to adhere97 and can possibly prevent recurrent infections33 but 
is not effective as a treatment42. The safety in pregnancy is not well documented. The 
effect of dandelion and horsetail is believed to be diuretic but documentation for 
safety and efficacy in pregnancy is lacking and a diuretic is not an adequate treatment 
for UTI. A preliminary study from 1993 showed that a combination of bearberry and 
dandelion might reduce the recurrence rate of UTI in women98 but no further 
documentation is available and the safety is not documented either. 
 
1.4 Why is it important to study herb use in pregnancy? 
Herbs have been used in pregnancy all through history. Knowledge about herbs has 
been passed on between generations and all times have had their herbal healers. As 
time went by, the knowledge and experience was collected and books like 
Culpepper’s Complete Herbal and English Physician99 or Gerard’s herbal100 came up. 
Very little evidence based knowledge is available even now.  
The challenge in pregnancy is to use only remedies which are safe for both mother 
and foetus. It is important to get to know which herbs are commonly used and by 
whom because when more is known about that, it is possible to do research on those 
herbs and gain evidence of safety and efficacy.  
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A solution might be to warn against all herb use in pregnancy, but due to long 
traditions and fear of unwanted effects of pharmaceuticals it is not possible to keep 
pregnant women from using herbs. It is probably not necessary either but more 
knowledge is needed before health care personnel can recommend herbs and discuss 
herb use with pregnant women on an evidence base.  
 
1.5 Pharmacoepidemiology – a brief introduction 
Pharmacoepidemiology is the study of the use of and the effects of drugs in large 
numbers of people101. The major use of pharmacoepidemiology is in post marketing 
drug surveillance and the subject has developed since the Thalidomide® disaster in 
the early 1960s. Post marketing surveillance is routinely performed by as well 
authorities as manufacturers of drugs. The aim is to gain supplementary information 
about the drug  like more precise information about incidence of known adverse and 
beneficial effects, information from patient groups not studied pre marketing, 
knowledge about interactions, comparison to other drugs for similar indications, 
discover new (adverse) effects, effect over time, effect of an overdose. 
Pharmacoepidemiology contributes to our knowledge about the safety of drug use by 
applying the methods of epidemiology to the area of clinical pharmacology. 
Pharmacoepidemiology is not widely used when it comes to herbal remedies as post 
marketing surveillance is not performed to any mentionable extent by authorities or 
manufacturers. 
 
1.5.1 Study designs in pharmacoepidemiology 
The various study designs used in pharmacoepidemiology and their advantages and 
disadvantages are shown in Table 2101. 
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Table 2 Study designs in pharmacoepidemiology 
Design Description Advantages Disadvantages 
Case report Description of an observed event. Single 
patient 
Raise hypothesis No hypothesis testing 
Case series Description of: 
- clinical outcomes from a collection of 
patients exposed to the same drug or 
- exposures of a collection of patients 
showing the same symptoms 
 
Raise hypothesis 
Quantitate incidents 
No hypothesis testing 
Trend analysis Trends in exposure which is considered the 
cause and trends in a disease considered 
the effect are compared to see if they 
coincide. 
Quickly get an overview of 
the probability of a 
hypothesis 
Can not be controlled for 
confounding 
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Case-control 
study 
Compares cases (with disease) to controls 
(without disease) and looks for differences 
in previous exposure. 
 
Study: 
- Multiple exposures 
- Uncommon diseases  
Data are possibly biased as they are 
collected retrospectively 
Cohort study Identifies subsets (exposed/not exposed, 
different exposition) of a population and 
follows them over time to look for 
differences in their outcome. 
 
Study: 
- Multiple outcomes 
- Uncommon exposures 
Prospective is time consuming 
Retrospective causes bias 
Randomised 
clinical trial 
Patients are randomly and blindly allocated 
to treatment or control groups  
“Gold standard” 
Comparable groups  
Controls for confounders 
Expensive 
Logistically difficult 
Ethical considerations 
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1.5.2 Types of errors 
Important issues in the described study designs are sample size and bias. 
In statistic tests a significance level of 0.05 (or a 95% confidence interval) is 
commonly applied. To achieve the significance level, a minimum sample size is 
necessary. Too small samples may give inaccurate results and too large samples will 
waste resources. Methods for sample size calculations can be found in relevant 
textbooks101. 
Various types of bias can occur in pharmacoepidemiological studies102. 
Selection bias origins from the method of recruitment into the study or to losses to 
follow up. It is seen when groups of subjects who differ from those in the target 
population are selected into the study. One way is if the referral to the study is related 
to drug exposure status (referral bias). Another is self selection bias which occurs 
when a participant herself decides to participate in or leave the study (this might be 
the case in the survey described in Chapter 2 – women using herbal remedies might 
more easily choose to participate in the survey about herb use in pregnancy because 
they have a special interest in the topic. This will lead to an over-estimation of the 
amount of herb users in the population.). 
Information and misclassification bias origins from the classification of a participant 
with respect to exposure or disease. Two kinds of bias are common in this category: 
Recall bias is important in retrospective studies – for instance, a mother with an 
impaired baby may give a more thorough description of her drug use in pregnancy 
than a mother with a healthy child. Or the recall of the drugs used may be more 
difficult as time passes. Detection bias occurs when for instance the questioning about 
exposure is more thorough in cases than in controls. 
Confounding occurs when the estimate of a measure of association between variable 
and outcome is disturbed by an extraneous variable (the confounder) – for instance 
another pharmaceutical used by the patient.  
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As well selection bias as information bias will have to be dealt with in the design 
phase of the study since their presence affects the study validity and can not be 
compensated afterwards. The effect of confounding can be dealt with in both design 
and analysis phases.   
 41 
2. Materials and methods 
The studies included in this thesis are based on two different study populations. One 
study is based on the Swedish Medical Birth Register of 860215 women giving birth 
between 1995 and 2004. The other studies are based on 578 women attending 
antenatal care at the Norfolk and Norwich University Hospital between November 
2007 and February 2008. 
 
2.1 The database study (Paper I) 
2.1.1 Aim 
To study characteristics of women using herbal remedies in early pregnancy and the 
possible impact of this use on pregnancy outcome. 
 
2.1.2 Study population 
The Swedish Medical Birth Register collects data on antenatal care, pregnancy and 
outcome of birth from nearly all deliveries in Sweden and the quality of the data has 
been evaluated at various times103,104. The study includes all births registered between 
1st of July 1995 and 31st of December 2004. The register was complete for 2004 at the 
time of study. In total 860215 women gave birth to 872377 infants during the study 
period.  
 
2.1.3 Data collection 
The data in the register are based on copies of the original medical records which are 
identical all over Sweden. Swedish women usually come to antenatal clinic before 
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they are 12 weeks pregnant, and during this first visit they are interviewed by a 
midwife. Among many questions, they are asked about smoking habits and the use of 
drugs – specified as prescription drugs, OTC drugs and herbal remedies. This means 
that the information mainly refers to first trimester use. Drug names are recorded in 
clear text and are later recoded into therapeutic classes according to the Anatomical 
Therapeutic Chemical Classification System for drugs (ATC)105 but as very few 
herbal products have such codes, the names in the register remain mainly as clear text. 
Data for maternal education as an indication for social level were obtained by linkage 
with the Central Register of Education (Statistics Sweden) but were only available for 
births up to and including 2001. Additional data for congenital malformations were 
obtained from the Register of Congenital Malformations and from the Hospital 
Discharge Register. 
 
2.1.4 Variables 
The descriptive variables studied were: 
• Maternal age at pregnancy (<25, 25-34, ≥ 35 years). 
• Maternal parity (a woman having her first infant is said to be parity 1, divided 
into parity 1, 2, 3, and 4 or more). 
• Maternal smoking (unknown, none, <10 cigarettes per day, 10 or more 
cigarettes per day). 
• Previous miscarriages (none, 1, 2, 3 or more). 
• Involuntary childlessness (number of years the couple has tried for the woman 
to become pregnant, none, 1, 2, 3, 4, 5 or more). 
• Mother’s country of birth (Sweden, other Nordic country, non-Nordic country). 
• Maternal BMI (Body Mass Index, < 19.8, 19.8 – 25.9, 26.0 – 29.9, ≥ 30.0, ≥ 
26.0). 
• Maternal education level (only available up to and including 2001, unknown, ≤ 
9, 10 – 13, 14 – 15, ≥ 16 years). 
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The outcome variables studied were: 
• Number of infants in pregnancy. 
• Preterm delivery defined as born before 37th week. (Only singleton infants). 
• Low birth weight defined as less than 2500 g. (Only singleton infants). 
• “Small for gestation age” (SGA) defined as less than 2 standard deviations 
below expected weight15. (Only singleton infants). 
• “Large for gestation age” (LGA) defined as more than 2 standard deviations 
above expected weight15. (Only singleton infants). 
• Low Apgar score (< 7) at 5 minutes. 
• Congenital malformations (Relative severe malformations means that infants 
with only the following malformation diagnoses are not counted as malformed: 
Patent ductus arteriosus in a preterm infant, preauricular appendix, 
undescended testicle, unstable hip, tongue tie, single umbilical artery, nevus). 
 
2.2. Survey (paper II and III) 
2.2.1 Aim 
To describe the use and the user of herbal remedies during pregnancy and to evaluate 
this use with reference to literature. To study the sources of information about herbs 
used and if possible to identify the most probable users by comparing characteristics 
for women using herbal preparations during pregnancy to those not using herbal 
preparations. 
 
2.2.2 Study population 
Expectant mothers at least 20 weeks pregnant presenting at the antenatal clinics held 
within Norfolk and Norwich University Hospital teaching hospital between 26th of 
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November 2007 and 15th of February 2008 made up the study population. 1037 
questionnaires were handed out and 578 were returned. 
 
2.2.3 Data collection 
The women were asked by the clinic receptionist if they would care to have a word 
with the pharmacist about some research while they waited. If they approached the 
pharmacist in the waiting room, they were explained the aim of the study and given a 
patient information leaflet, a questionnaire and a stamped addressed envelope. 
The survey was based on a questionnaire developed by Nordeng at the University of 
Oslo, Norway70. To clarify what kind of remedies the study was concerned about, the 
following definition of an “herbal preparation or medicine” was given in the 
questionnaire: “any kind of product, such as a tablet, a mixture, an ointment or herbal 
teas which are produced from plants and used to acquire better health”. See Appendix 
C for original questionnaire. 
 
2.2.4 Variables 
The following sociodemographic and lifestyle data were collected:   
• Year of birth. 
• Number of pregnancies prior to this one. 
• Marital status. 
• Smoking during pregnancy. 
• Medicines taken regularly. 
• Education level. 
• Occupation (if housewife, partner’s occupation). 
• Payment for prescription medicines (as a proxy for social status). 
Other variables studied were: 
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• Prior use of herbal remedies with specific questions regarding 9 different 
herbs: 
o Echinacea (coneflower). 
o Floradix®. 
o Ginger. 
o Chamomile. 
o Valerian. 
o Cranberry. 
o Horsetail.  
o Raspberry leaf. 
o St. John’s wort.  
These herbs were originally selected because they (except from raspberry leaf) were 
the ones with an authorisation as herbal medicinal products according to the 
Norwegian legislation. Raspberry leaf was known to be used especially in pregnancy. 
For each product participants were asked if they were aware of it and if so – whether 
they had used it during pregnancy and if so – what condition they had used it for, 
when during pregnancy (trimester) and for how long time. An open question about 
other herbal remedies used was also included. Participants who had used herbal 
remedies were asked about: 
• Who recommended it to them. 
• Whether or not they had told their doctor about the use. 
All participants were asked: 
• If they had other children that were breastfed and if so: 
o If they had used herbal remedies to increase milk production. 
• Whether they expected to use herbs in the future. 
• Where they would go/look for information about herbs in the future. 
• Medical conditions experienced during pregnancy, when experienced and how 
treated: 
o Nausea, vomiting or morning sickness (NVP). 
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o Fatigue. 
o Indigestion or heartburn. 
o Common cold. 
o UTI. 
o Swollen ankles. 
o Other conditions – specify condition, time and treatment. 
Three statements from the “Beliefs about medicines questionnaire”106 were included 
to evaluate the participants’ attitudes towards medicines and herbs. The statements 
were answered on a 5 point Likert scale from “Strongly agree” to “Strongly disagree”.  
• Medicines do more harm than good. 
• Natural remedies are safer than medicines. 
• If doctors had more time with patients they would prescribe fewer medicines. 
 
2.3 Focus group discussion (Paper IV) 
2.3.1 Aim 
To gain a better understanding of women’s reasons for use of herbal remedies during 
pregnancy. 
 
2.3.2 Study population 
All participants in the survey were also invited to claim their interest in the focus 
group discussions by submitting, in a separate envelope, name, address, phone 
number and information about whether they had used herbs in pregnancy or not. 
Thirty four users and 18 non-users were interested in participating. The intention was 
to have two focus group discussions – one for users and one for non-users. All non-
users and 18 randomly selected users were invited for the focus group discussions. 
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Only one non-user was willing to attend so this focus group discussion never took 
place. Seven users agreed to attend and six participated. 
 
2.3.3 Data collection 
The focus group discussion took place at the University of East Anglia, Norwich, UK. 
A moderator (Ph.D. student) and her academic supervisor were present. 
The discussion was recorded on two digital recorders and transcribed verbatim.  
 
2.3.4 Variables 
The attendees were asked to provide explanations for the following results from the 
survey: 
• 57.8 % used one or more herbal remedies during pregnancy compared to non-
UK studies which found between 4.1 – 56 %. 
• Users of herbal remedies tended to “Disagree” that “Medicines do more harm 
than good”.  
• The most important source of information about herbal remedies actually used 
during pregnancy was “Family and friends”.  
• The use of herbal tea to increase production of breast milk was rare (3.3 % 
compared to 43.3 % in Norway). 
• Only 4.5 % reported taking Iron supplements against fatigue. 
Attendees were also asked to clarify the following:  
• Is ginger a herbal remedy – why or why not? 
• Why use herbal remedies at all when we have lots of medicines available both 
OTC and on prescription? 
o Safety. 
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o Efficacy. 
o Cost. 
 
2.4 Review (Paper V)  
The electronic databases PubMed, ISI Web of Science, Natural Medicines 
Comprehensive Database and Cochrane Library were searched. The search words: 
“safety” or “efficacy” in combination with “pregnant” or “pregnancy” in combination 
with “raspberry” or “Rubus idaeus” were used. Articles with focus on safety or 
efficacy during pregnancy, pharmacology and in vitro tests explaining mode of action 
were selected. Another search with the words “raspberry” or “Rubus idaeus” and 
“constituents” was performed and articles with focus on constituents in Rubus idaeus 
(not other Rubus sp) were selected. References in the literature found were also 
studied. 
The aim of this study was to review the literature about safety, efficacy, constituents 
and possible modes of action of raspberry leaf in pregnancy. 
 
2.5 Statistic and other methods of analysis used 
2.5.1 For the database study 
Women who had used herbal drugs were compared to all women who had given birth 
during the study period. Infants of the first group were compared to infants of the 
second. Mantel-Haenszel procedure was used to estimate odds ratio (OR) and 95% 
confidence intervals (95% CI) were determined using Miettinen’s method107.  
 
2.5.2 For the survey 
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Chi-square tests were used to analyse univariate associations between variables. A 
significance level of 0.05 was applied. 
Logistic regression was used to study associations between sociodemographic and 
lifestyle-variables and use of herbal remedies during pregnancy. Forward logistic 
regression analysis was used to generate models. Variables related to use of herbal 
remedies with significance level of 0.05 or greater were included into the model. 
Interaction factors were included in addition to single variables where appropriate.  
The statistical analyses were performed using Statistical Packages for Social Sciences 
(SPSS) version 15. 
 
2.5.3 For the focus group 
The transcript was analysed according to Colaizzi’s method of content analysis108.  
• Read the transcript to acquire a feeling for it. 
• Review the transcript to extract significant statements. 
• Formulate meanings for each significant statement. 
• Organize the formulated meanings into clusters of themes. 
o Refer the clusters back to the original protocol to validate them. 
o Note discrepancies among and/or between the clusters. 
• Integrate the results into a description of the phenomenon under study. 
The transcripts and the extracted themes were sent to the participants to validate the 
interpretation and to obtain further comments. 
Four criteria have been suggested as the “gold standard” for establishing 
trustworthiness of qualitative data: credibility, dependability, confirmability and 
transferability109. To achieve credibility each of the members of the focus group were 
asked to comment on the researcher’s interpretation of the data. Co-author David 
Wright listened to the tape and scrutinised the transcripts to achieve dependability and 
 50 
confirmability. Transferability was enhanced by including women unrelated to one 
another and coming from different parts of Norfolk. It was supported by inclusion of 
verbatim quotes in the manuscript to be published to allow the reader to evaluate. 
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3. Main results 
This thesis is based on three different studies, two of which are related, and a review. 
One study is based on data from 860215 women in the Swedish Medical Birth 
Register. The second study is based on a survey among 578 women at the Norfolk and 
Norwich University Hospital and the third study is based on a focus group discussion 
between 6 women from the same population. 
 
The main findings in this thesis were: 
Data from survey and focus group discussion among women from Norfolk: 
• 57.8% (334 women) of the participants 20 weeks or more pregnant had used 
herbs and the usage was 1-10 herbs pr woman. 
• The most commonly used herbs were ginger, cranberry and raspberry leaf, see 
Figure 1 (numbers according to question 2-11, see appendix C). 
• Herbal galactagogues had been used by only 3.3%. 
• Family and friends were the most used source of information about herbs used 
in pregnancy, see Figure 2, and more than 75% did not inform their doctor or 
midwife about the herb use. 
•  Nausea and vomiting (NVP) was the condition most commonly treated with 
herbs and overall the pregnancy-related condition most commonly treated. 
• 41 different herbs were reported used, 96 different indications were given for 
the use and only 50 of those could be confirmed in literature as “traditionally 
used”. The most used herbs and the reasons for use are given in Table 3 
(numbers adjusted according to questions 17-23). 
• 41.2% of the participants had used potentially harmful herbs or herbs for 
which the documentation for safety in pregnancy was inadequate.  
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• Of all 578 participants 232 (40.1%) had used pharmaceuticals sometime during 
pregnancy AND herbs sometime during pregnancy. Seventy one (12.3%) used 
drugs regularly AND used herbs sometime during pregnancy. 
• The typical user had been pregnant before and had a university degree. 
• Significantly more users (45.2%) than non-users (33.2%) of herbs in pregnancy 
agreed with the statement “If doctors had more time with patients they would 
prescribe fewer medicines”. 
• The users of herbs expected herb use in pregnancy to be an “underground” 
thing. 
• The users relied on family and friends for information – they did not expect 
doctors to be interested in or knowledgeable about herbs and found it difficult 
to evaluate the reputability of alternative practitioners so avoided them. 
• The users knew that documentation for safety of herbs was inadequate but 
considered them to be safer than pharmaceuticals anyway. 
• The users wanted the NHS (National Health Service, UK) to be more open 
minded. 
 53 
0
20
40
60
80
100
120
140
160
180
Ec
hin
ac
ea
Flo
ra
dix
®
Gin
ge
r
Ch
am
om
ile
Va
ler
ian
Cr
an
be
rry
Ho
rs
eta
il
Ra
spb
er
ry 
lea
f
St.
 
Joh
n's
 
w
or
t
Pe
pp
er
m
int
La
ve
nd
er
Nu
m
be
r 
o
f u
se
rs
 
Figure 1. Number of users of the various herbs (survey.) 
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Figure 2. Sources of information used about the herbs used during pregnancy in 
the survey 
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Table 3. The most commonly used herbs and the reasons for use (n=578) 
Plant Users Most commonly reported reasons for use (no) 
Morning sickness (107) 
Nausea (37) 
NVP (35) 
Indigestion (9) 
Other, confirmed (7) 
Ginger 
(Zingiber officinalis) 
194 
(33.6%) 
 
Other, not confirmed (12) 
Treat UTI (69) 
Prevent UTI (23) 
Vaginal thrush* (7) 
Other, confirmed (2) 
Cranberry 
(Vaccinium 
macrocarpon) 
146 
(25.3%) 
Other, not confirmed (12) 
Induce and ease labour (59) 
Tone/prepare uterus for labour (18) 
Soften/prepare cervix (10) 
Strengthen uterus (6) 
Other, confirmed (4) 
Raspberry leaf (Rubus 
idaeus) 
137 
(23.7%) 
Other, not confirmed (8) 
Relax (26) 
Sleep (14) 
Calming (7) 
Other, confirmed (8) 
Chamomile, German  
(Matricaria recutita) 
And 
Chamomile, Roman 
(Chamaemelum nobile) 
76 
(13.1%) 
Other, not confirmed (2) 
*Indications marked with * could not be confirmed in literature. NVP = nausea and vomiting in pregnancy, UTI 
= urinary tract infections. Numbers may not add up as each person could use one herb for more than one 
purpose.
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Data from the Swedish Medical Birth Register: 
• 0.9% (787 women) of the population had used herbs during the first 12 weeks 
of pregnancy and the usage was 1-3 herbs pr woman.  
• The typical user was 35 years or older and had 14-15 years of education 
(Bachelors degree).  
• The most commonly used herbs were Floradix® (iron rich herbs), ginseng and 
valerian, see Figure 3. 
• Concomitant drug use was common.  
• None of the infant characteristics studied were influenced significantly by the 
herb use. 
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Figure 3. Number of users of the various herbs (database study).
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Review 
• Raspberry leaf tea has traditionally been used to relieve nausea, strengthen, 
tone or prepare uterus, soften or prepare cervix and induce or ease labour. This 
use is described in old herbals. 
• The first scientific documentation known is from 1941. It was found that toned 
smooth muscles were relaxed by raspberry leaf while relaxed muscles were 
contracted. The active constituent was not identified. 
• Even in 2002 neither active constituents nor mode of action are known.  
• A retrospective study from 1998/1999 and a clinical trial from 2001/2002 
showed no adverse effects on mother or baby but no statistically significant 
effects either. 
• Trend (insignificant) towards reduced likelihood of need for artificial rupture 
of membranes was discovered in the test group as well as mentionable shorter 
duration of respectively the first stage and the second stage of labour in the two 
studies. 
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4. General discussion 
4.1 Comparisons between studies  
A list of studies of herb use in pregnancy in the western world from 2001 to 2008 are 
given in Appendix B. Ten out of the 13 studies are relevant for comparison to the 
studies in this thesis (see 1.2.1). Eight of those were performed in antenatal clinic, one 
in postnatal ward and one was a mail survey. Five studies were interview studies and 
five used self completed questionnaires. Four were from Australia, four from the US, 
one from Norway and one from Italy. The studies by Nordeng (Norway)70 and Forster 
(Australia)72 were the only ones designed specifically to study use of herbs in 
pregnancy – the other studies also included other alternative treatments, dietary 
supplements or prescription and OTC drugs. Forster was the only one to look into 
reasons for herb use in pregnancy72. The percentage of users in the studies varied 
between 7 and 56.   
 
In the database study (Paper I) only 0.9% of the women had used herbs during the 
first 12 weeks of pregnancy. This number is low compared to the other studies and it 
does not seem probable that such a big difference should be found between Norway 
(36% reported use)70 and Sweden, but various explanations for the findings can be 
discussed. One explanation can be that the results describe use early in pregnancy. It 
can be argued that NVP is common at this time and one would expect more than 0.6% 
of the women to use ginger to treat it but NVP is commonly treated with 
antihistamines in Sweden110. This means that the women will not be left with only 
dietary advice to treat the most common condition in early pregnancy and it is 
probable that fewer will try herbal remedies. Another explanation can be that though 
all women were questioned according to a standard national questionnaire, they were 
questioned by different midwives with different attitudes towards herbs. Reporting of 
herb use was not the main aim of the questioning and it is not known how detailed the 
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questioning was (information bias discussed in 4.2.1.2). There is a good reason to 
believe that the herb use is under-reported in this study and it would be interesting to 
perform a survey similar to the one performed at Norfolk and Norwich University 
Hospital in a Swedish hospital. 
In the survey (Paper II and III) 57.8% of the women, who were at least 20 weeks 
pregnant reported use of herbs. This percentage is comparable to other similar 
studies8,66,68 but higher than most. One possible explanation can be selection bias as 
discussed in 4.2.2.1  
 
The most used herbal remedy in the database study, Floradix®, was used by 34.7% of 
the herb users compared to 12.8% in the survey, 11.8% in the Norwegian study70 and 
no reports in any other study. National differences and year(s) of data collection can 
possibly explain part of this finding. Just like all other phenomena in a community, 
various herbal remedies are popular at various times. Floradix® is a German product 
and the way to Scandinavia and the UK has probably been shorter and easier than the 
way to the USA or Australia explaining why this product was used to such a high 
extent in Sweden between 1995 and 2004, in the UK in 2007-8 and in Norway in 
2003-4 while not reported used in the USA and Australia at all at the same time.  
 
A description of “the typical herb user” would be very convenient as it would enable 
health care personnel to be more alert when interviewing “her” about drug use and 
herb use in pregnancy but it is difficult to find. In the database study she was 35 years 
or older and had 14-15 years of education (Bachelors degree) while in the survey she 
had been pregnant before and had a university degree. Other studies found “the 
typical user” to be: 
• Younger than 3670. 
• Primigravada, married, having tertiary education67. 
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• Prior user of herbs. Trend (not significant): white, at least college education61. 
• Trend (not significant): 41 – 50 years old63. 
• Higher age, have a degree, English as first language, non-smoker, 
primigravada72. 
All together it seems sensible to conclude that higher age and higher education 
indicate higher probability for herb use in pregnancy but as the Norwegian study70 
found an opposition to this, all pregnant women should be interviewed closely about 
their eventual herb use. Unpublished data from the focus group discussion showed 
that three out of six women used herbs because they were brought up to do it while 
one got scared of side effects of pharmaceuticals from seeing her mother getting 
cancer treatment. This also indicates that it can be difficult to describe a typical user 
from demographic data and thus that all women should be interviewed. 
 
Many different herbs were reported used. The survey showed 41 different herbs 
which is comparable to the 46 found in the Norwegian study70. The use of potentially 
harmful herbs or herbs for which the documentation for safety in pregnancy is 
inadequate is also similar in the two studies; 41.2% in this survey and 39% in the 
Norwegian study70. This mainly reflects the lack of safety documentation of herbal 
remedies in pregnancy and not a documented risk of harm. 
Forty eight percent of the reasons given for use of the herbs in the survey were not 
confirmed in literature on traditional or modern use of herbal remedies1,48. This gives 
rise to concern because it is impossible to evaluate whether potential benefit 
outweighs potential risk. The majority of those not described reasons are given by just 
one or a few women but the use of cranberry to treat vaginal thrush is mentioned by 7 
women. Thrush is a fungal infection most commonly caused by Candida albicans. A 
weak effect of cranberry on Candida albicans in urine is shown111 but nothing is 
found about bioavailability or effect on vaginal thrush. 
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Concomitant use of herbs and pharmaceuticals was described in both studies. Such 
use is also described in other studies8,62 and causes a risk of interactions. No 
potentially serious interactions were identified in the survey but in the database study 
concomitant use of valerian and psycholeptics was reported by 12 out of 98 users of 
valerian. This combination may cause excessive sedation1.  
 
The most important source of information about the herbs used during pregnancy was 
“family and friends”. This is similar to findings in other studies67,68,70,72. The women 
in the focus group explained this by the expected lack of knowledge among health 
care personnel, the difficulty in finding a reputable alternative practitioner and  the 
desire to get information from as many people as possible and then making up their 
mind (see below). 
 
Herbal galactagogues were used by only 3.3% of the 241 women who had prior 
children that were breastfed. This is very little compared to the 43.3% reported in the 
Norwegian study70. According to the women in the focus group many British women 
found breastfeeding inconvenient and gave up early. Some suggested that knowledge 
about herbal galactagogues would be useful for those women but others in the group 
thought that it would be considered “a nightmare” because it would somehow force 
women to continue trying to breastfeed.  The effect of herbal galactagogues is not 
well documented and should not be encouraged according to Nordeng70. 
 
The focus group discussion (Paper IV) was performed to get a better understanding of 
the women’s attitudes towards herbs and reasons for choosing herbal remedies instead 
of pharmaceuticals. A belief in herbs as natural and thus safe was expressed. The lack 
of scientific documentation and the fact that anything with an effect can have side 
effects was acknowledged but the belief in safety was stronger. 
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The women did not believe that doctors or other health care personnel were interested 
in herbs or had any particular knowledge about them – they rather expected them to 
disapprove of herb use and thus did not discuss their herb use with them. The 
expected lack of knowledge is documented in various studies (see 1.1.7) indicating 
that health care personnel should learn more about herbal remedies to be able to give 
advice46,57-60. On the other hand the women found it difficult to find a reputable 
alternative practitioner due to the lack of regulation of those (only therapists of 
chiropractic and osteopathy are regulated in the UK by now, but the Department of 
Health works to regulate acupuncture, herbal medicine and traditional Chinese 
medicine practitioners as well within a year or two). Still they wanted the NHS to be 
more open minded and to include alternative practitioners in their services. Though 
they described doctors as “drug pushers” unwilling to listen to them and discuss 
treatment alternatives, they seemed to trust the NHS to be able to select reputable 
alternative practitioners for collaboration. This seems somehow contradictive but is 
possibly based on a wish to be responsible for own health, be involved in decisions, 
consider all possible treatments and still feel safe. The NHS is considered the 
guarantor for this safety.  
 
The literature review in papers III and V show that there is a lack of scientific 
documentation of the safety and efficacy of many herbs commonly used in pregnancy. 
This is also described in chapter 1.1. Raspberry leaf has been used in pregnancy for a 
very long time and some practitioners consider this an adequate documentation for 
safety; “if it was not safe, we would have known by now”112. Others recommend 
avoidance of a herb in pregnancy until positive evidence for safety is available49. 
Health care personnel have to give evidence based advice but this is not available for 
most herbs both due to the lack of clinical trials or other studies of efficacy and safety 
and due to the lack of pharmacovigilance which is not compulsory for herbal products 
yet (see 1.1).  
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4.2 Limitations and methodological considerations  
4.2.1 The database study 
The use of data from an established database in research is common when 
quantitative data are wanted. The Swedish Medical Birth Register consists of data 
from standard interviews of pregnant women at their first antenatal visit before they 
are 12 weeks pregnant. The advantages of an established database compared to a 
survey are that a large sample is available to ensure the validity of prevalence 
estimates (in this case more than 800.000 pregnant women) and that money as well as 
time is saved. A disadvantage is that questions are already asked, so the study must 
adapt to that and not vice versa. 
 
 4.2.1.1 Selection bias 
na. 
 4.2.1.2 Information bias 
The main concern in the database study is the possible incomplete registration of herb 
use caused by the varying interest in or concern about herbal remedies among the 
midwives interviewing the pregnant women. The incomplete registration will cause 
some exposed women to be registered as unexposed which will bias the associations 
and risk estimates and thus reduce the potential for identifying an existing association. 
The large number of women in the study increases the statistical power and might 
outweigh the bias. 
The fact that the interviews are performed before the outcome of pregnancy is known 
makes exposure information prospective in relation to outcome and eliminates recall 
bias caused by the outcome.  
 4.2.1.3 Confounding 
 63 
Adjustment for confounding factors was performed with respect to maternal age, year 
of pregnancy, parity, smoking and previous miscarriages according to experience at 
the Swedish Medical Birth Register. 
 4.2.1.4 External validity of results 
The Swedish Medical Birth Register collects data on antenatal care, pregnancy and 
outcome of birth from nearly all deliveries in Sweden. The data are based on copies of 
the original medical records which are identical all over Sweden. Antenatal care is 
free of charge and nearly all women attend this service. The only disadvantage is that 
record of herb use is taken at the first visit around 12th pregnancy week and no data 
are available about use later in pregnancy. This means that the data can not be used as 
an estimate of the prevalence of herb use. Though the first trimester is the period of 
organogenesis the bias mentioned above (4.2.1.2) makes conclusions about safety of 
the used herbs uncertain.  
 
4.2.2 The survey 
Surveys generally involve the systematic, structured questioning of a statistically valid 
sample of people113. The sample for this survey was calculated from results from a 
study by Nordeng70 showing that 36% of the study population used herbal remedies, 
an acceptable standard error of +/- 2% and the following mathematics: 
SE = 
n
pp )100( −
 (according to Haraldsen114) showing that a sample size n = 600 
would satisfy the conditions. 
A survey can be undertaken as a self-completed questionnaire or as a structured 
interview. It involves no active intervention by the investigator. In this case a self-
completed questionnaire was chosen because it was considered  an appropriate way to 
obtain the descriptive information needed, it was less labour consuming and possible 
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for a person with English as a second language to perform within the dedicated time 
period. 
 
 4.2.2.1 Selection bias 
The bias of concern is “self selection bias” – the women in the study have chosen to 
participate (submit the completed questionnaire) and women using herbal remedies 
might be more prone to participate in a survey about herb use in pregnancy because 
they have a special interest in the topic. This will lead to an over-estimation of the 
amount of herb users in the population.  
 4.2.2.2 Information bias 
Like in the database study, the questionnaires were completed before outcome of 
pregnancy was known thus eliminating recall bias caused by this. Recall bias caused 
by time is not considered very important as the period of time is not very long and as 
both herb/disease specific and open ended questions were asked. 
 4.2.2.3 Confounding 
In paper II, multivariate logistic regression was used to control for confounding. 
Variables related to use of herbal remedies with significance level of 0.05 or greater 
were included into the model. Interaction factors were included in addition to single 
variables where appropriate. 
 4.2.2.4 External validity of results 
Sample size was calculated according to known parameters and statistical methods 
and should therefore be adequate. The study was carried out in the antenatal clinic of 
one hospital in one region of the UK and though women from both rural and urban 
areas come to this clinic the respondents may not be representative of the pregnant 
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population in the UK. The results may also not be generalisable with a 56% response 
rate. 
 
4.2.3 The focus group discussion 
A focus group discussion is a group interview technique for collection of qualitative 
data. It is commonly known from marketing research but also useful in other 
disciplines where knowledge about peoples’ views, experiences, concerns and 
priorities is sought to explain behaviour. It is the intention that participants shall 
interact with one another in discussing the selected issues and forming opinions like 
people do in everyday life. In this way points relevant for the issues discussed will 
come clear as more or less important in the group. It is common to have more than 
one group discussion on an issue to make sure that all relevant points come up. One 
advantage of the method is that many different points come up and are discussed but 
of course some participants might feel less comfortable in the situation and thus not 
participate as eagerly as others. To compensate for that, focus group discussions are 
sometimes combined with individual interviews. In this case two focus group 
discussions were planned but only one was held as the possible participants of the 
other were unable to attend or no longer interested. This means that the issue is not 
completely studied, but the points which came up are considered important for the 
care of pregnant women and should thus be published for health care personnel. 
 
The main concern in the focus group study is the fact that only one focus group 
discussion was performed. This is a disadvantage (see 2.6.3) and the study must be 
considered a pilot study. 
 66 
5. Conclusions and future perspectives 
More than half of the women in the survey from the Norfolk and Norwich University 
Hospital used herbs during pregnancy and more than 75% of the users reported that 
they did not inform their health care provider about the use. The focus group 
discussion gave an explanation to why women omit informing health care personnel: 
The women expected or had experienced a negative attitude to herbs among health 
care personnel – “I went to ask mine (midwife) about raspberry leaf and she 
practically laughed me out of the office” - and did not expect them to have any 
knowledge about herbs either.  
 
It is still not possible to describe “the typical herb user” so all pregnant women should 
be asked about herb use and health care personnel should be able to give evidence 
based advice on the use. To do this it is necessary to have knowledge about as well 
traditional use as scientific documentation. Unfortunately; with few exceptions there 
is still a lack of well-conducted studies on the safety and efficacy of herbs in 
pregnancy.  
Data from the Swedish Medical Birth Register did not indicate any influence on 
premature birth, birth weight, small or large for gestational age, Apgar score or 
congenital malformations of the newborn from maternal use of specific herbs during 
first trimester. The number of registered exposures, however, was low and it is not 
known how thoroughly the “herbal drug history” was taken in each case so this study 
does not document the safety of the used herbs and probably not the degree of herb 
usage either.  
 
The studies performed for this thesis and similar studies in other countries show 
which herbs pregnant women use and form the base of future work with many 
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challenges. The first one is to design and perform studies to document as well safety 
as efficacy of herbs during pregnancy. Controlled clinical trials are preferred but will 
probably be difficult for practical as well as economical and ethical reasons so 
prospective observational studies regarding herbal remedy usage and pregnancy 
outcome are warranted to determine safety.  
 
The existing and relatively new EU legislation allows sale of many herbal products as 
“food supplements”. This does not prompt further studies of safety or efficacy or the 
development of evidence based patient information leaflets. When a product can be 
marketed as a food supplement after a notification to the relevant authorities there are 
few good reasons for manufacturers to collect documentation or even do clinical trials 
with all the involved costs, to acquire a marketing authorisation for a herbal product 
as a traditional or well established herbal medicinal product. 
 
The six women in the focus group were all aware of the lack of scientific safety 
documentation of their herb use. Anyway they were certain that herbs were generally 
safer than pharmaceuticals and that even though some herbs had side effects, the 
herbs they used were safe. Here is another challenge for the future – communication 
of scientific data to the public. Preliminary data from the survey were presented at the 
British Pharmaceutical Conference 2008 and a journalist from Daily Mail quoted part 
of it in the newspaper. Nine comments from readers were added during the first day 
after publication. They ranged from “More scare stories to get people to give up 
herbal supplements” to “Herbal remedies can be as potent as pharmacy medicine and 
should be avoided in pregnancy because unborn babies can be affected by these as 
much as any other medicine” and included women’s’ own experience as 
“documentation” for safety. This shows that the way we communicate the results and 
recommendations is crucial. 
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The way information is communicated is related to the competence of the person who 
gives the information. A third challenge for the future is to introduce more education 
about herbal remedies in the training of health care personnel. For pharmacists this 
can be done by (re)introducing relevant courses in pharmacognosy in the curriculum 
and for other groups of health care personnel courses might need to be extended or 
developed. As the base of this education has to be scientific this leads back to the first 
challenge; it is necessary to do research to gain more knowledge about the safety and 
efficacy of herbs in pregnant women. 
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APPENDIX A 
Clinical trials and other human studies of herbal products used in pregnancy  
Author and year of 
publication 
Dose and duration Number of participants 
test:control 
Safety Efficacy 
Ginger 
Fischer-Rasmussen 
et al19  
1990 
1 g dry rhizome a day 
for 4 days 
30 (cross-over) No side effects. More effective against symptoms 
of hyperemesis gravidarum than 
placebo. 
Vutyavanich et al20 
2001 
1 g dry rhizome a day 
for 4 days 
32:38 No adverse effect on pregnancy 
outcome detected. 
More effective against nausea 
and vomiting than placebo. 
Keating & Chez21 
2002 
1 g dry rhizome a day 
for 2 weeks 
14:12 No significant side effects (but too 
few participants to reveal 
uncommon effects). 
May be useful in some patients 
experiencing nausea and 
vomiting. 
Sripramote & 
Lekhyananda22 
2003 
1,5 g dry rhizome a 
day for 3 days 
64:64 No significant side effects (but too 
few participants to reveal 
uncommon effects). 
Equivalent to Vitamin B6 against 
nausea and vomiting 
  
 
Willetts et al23 
2003 
500 mg extract equal 
to 6 g rhizome a day 
for 4 days + 4 days 
(ginger for both 
groups) 
60:60 No significant differences in 
outcome, but as both groups got 
ginger for the extra 4 days, there is 
no untreated control group. 
More effective against nausea 
than placebo. 
Portnoi et al24 
2003 
Various doses, in 
39% of cases 
combined with 
pharmaceuticals, used 
for 3 days or longer. 
187:187 (prospective) No significant differences in 
outcome. 
Capsules more effective than 
other forms. Almost half of the 
women found ginger totally 
ineffective. 
Smith et al25 
2004 
1050 mg dry rhizome 
a day for 3 weeks 
146:145 No differences between groups for 
complications or outcome. 
Equivalent to Vitamin B6 against 
nausea and vomiting 
Chittumma et al26 
2007 
650 mg dry rhizome 
3 times daily for 4 
days  
61:62 No significant difference in 
number of patients experiencing 
side effects. Side effects were all 
minor. 
Significantly greater reduction in 
nausea vomiting score than 
Vitamin B6 
  
 
Pongrojpaw et al27 
2007 
0.5 g dry ginger 2 
times daily for 7 days 
85:85  Ginger is as effective as 
dimenhydrinate in treatment of 
NVP and has fewer side effects. 
Ensiyeh & Sakineh28 
2008 
0.5 g dry ginger 2 
times daily for 4 days 
35:35 No adverse effects were seen. Significantly greater reduction in 
nausea score than Vitamin B6 
Cranberry 
Wing et al33 
2008 
240 ml 27% 
cranberry juice 
(special formulation) 
vs placebo (special 
formulation), 3 times 
daily (red. to 2 
times), from w16 
58:67:63 
(3 doses:1 + 2placebo: 
3 placebo) 
No differences between the groups 
with regard to obstetric or neonatal 
outcomes. 
Trend towards fewer UTI’s with 
multiple daily doses vs placebo 
and a weaker trend for a single 
daily dose. 
Raspberry leaf 
Parsons et al37 
1999 
Various doses, 
duration 1 – 32 weeks 
57:51 (retrospective) No identified adverse effects Some effect on shortening labour 
and less “mechanical assistance”. 
  
 
(not statistically significant) 
Simpson et al38 
2001 
Tablets, 2 x 1.2 g a 
day, from 32 weeks 
until labour. 
96:96 No adverse effects Did not shorten first stage of 
labour, but second with 9.59 
min., lower rate of forceps 
delivery 
(not statistically significant) 
Echinacea 
Gallo & Koren 
2000 
Doses: Tablets 250 – 
1000 mg/day. 
Tincture 5 – 30 
drops/day. Duration 
5-7 days. 
206:206 (prospective) No significant difference in 
abortions or malformations. 
na 
St. John’s wort 
Grush et al 
1998 
900 mg a day, from 
24 weeks until labour 
1 (case) No adverse effects na 
 
  
 
APPENDIX B 
Summary of studies identifying herbal medicine use in pregnancy 
 Gibson et al 
2001 
Tsui et al 2001 Hepner et al 2002 Hollyer et al 2002 Pinn et al 2002 Byrne et al 2002 Maats et al 2002 
Country USA USA USA Canada Australia Australia Australia 
Location Antenatal clinic Antenatal clinic Mail  Helpline Antenatal clinic Antenatal ward Antenatal clinic 
Method Survey Survey Survey Survey Survey Interview Interview 
N 250 150 1203 70 305 48 211 
% reported using 
herbal medicines 
9 
 
13 
 
7 
 
61.2   
(CAM) 
12 
 
56 
 
33.6/20.4/23.2 
1st/2nd/3rd trimester 
Chamomile X    2.7 44.4 12.7/30.2/26.5 
Peppermint  X     25.9  
Ginger  X 6.7 9.6 50.7 8.1 33.3 59.2/20.9/4.1 
Echinacea  X 8.9 36.5  5.4 3.7 2.8/9.3/6.1 
Ginseng  X  9.6   3.7  
Pregnancy tea  8.9      
Raspberry leaf  4.4   21.6 18.5 5.6/9.3/34.7 
Cranberry   7.7     
Ginkgo   9.6     
Evening Primrose   9.6  8.1   
St. Johns Wort   19.2  8.1 3.7  
Valerian    5.8  2.7 7.4  
Golden seal     2.7   
Barley     2.7   
Miso paste     2.7   
  
 
Noni juice     2.7   
Parsley     2.7   
Chinese herbs     13.5   
Slippery elm      3.7  
Dandelion      3.7  
Tea for sleep      3.7  
Unspecified     13.5 3.7  
Cocoa butter        
Licorice        
Green tea        
Witch hazel        
Kava kava        
alfalfa        
Blue cohosh        
Broccoli        
Cannabis        
Castor oil        
Coconut oil        
Fenugreek seed        
Nettle        
Oat straw        
Partridge berry 
leaf 
       
Yellow dock        
Iron rich herbs 
(Floradix ®) 
       
  
 
Horse tail        
Elderberry        
Almond oil        
Propolis        
Fennel         
Mauve        
The percentages given for each herbal product is percent of herb-users using this specific herb unless otherwise indicated. Some women use more than one herb. 
                  Cont.
  
 
  
 Glover et al 2003 Westfall 2003 Nordeng et al 2004  Refuerzo et al 2005 Forster et al 2006 Lapi et al 2008 
Country USA Canada Norway USA Australia Italy 
Location Rural obstetric 
clinic 
Various  Post-natal ward Post-natal ward Antenatal clinic Antenatal ward 
Method Interview Interview Interview Survey Survey Interview 
N 578  27 400 418 588 150 
% reported using 
herbal medicines 
45.2 
 
96  
 
36 
 
4.1 
(CAM) 
36 
 
48 
Chamomile 4.6 7.7 9.0  30.1 4.2 
Peppermint  39.8 23.1     
Ginger  1.9 23.1 10.4 0.21 32.1  
Echinacea  3.1 11.5 22.9  8.0  
Ginseng  5.4  X 11   
Pregnancy tea 17.6  6.9    
Raspberry leaf 2.3 84.6 X  39.2  
Cranberry 28.7 3.8 8.3  24.1  
Ginkgo 3.1   0.51   
Evening Primrose  7.7   5.2  
St. Johns Wort 1.9  X   4.2 
Valerian        
Golden seal       
Barley       
Miso paste       
Noni juice       
  
 
Parsley       
Chinese herbs     3.8  
Slippery elm     4.2  
Dandelion  3.8     
Tea for sleep       
Unspecified 2.7    4.2  
Cocoa butter 15.3      
Licorice 6.9   0.51   
Green tea 6.1      
Witch hazel 2.3      
Kava kava 1.1      
alfalfa  15.4     
Blue cohosh  11.5     
Broccoli  3.8     
Cannabis  3.8     
Castor oil  7.7     
Coconut oil  3.8     
Fenugreek seed  7.7     
Nettle  34.6     
Oat straw  3.8     
Partridge berry 
leaf 
 7.7     
Yellow dock  7.7     
Iron rich herbs 
(Floradix ®) 
  11.8    
Horse tail   5.6    
  
 
Elderberry   5.6    
Almond oil      27.8 
Propolis      19.4 
Fennel       15.3 
Mauve       
The percentages given for each herbal product is percent of herb-users using this specific herb unless otherwise indicated. Some women use more than one herb. 
1
 % of n = 418
  
 
APPENDIX C 
Questionnaire for the survey 
 
 Version 3  Oct 2007    
 
Use of herbal medicines during pregnancy 
 
 
 
 
Project led by Mrs Lone Holst 
   Visiting researcher 
   School of Chemical Sciences & Pharmacy 
   University of East Anglia 
   Norwich, NR4 7TJ 
 
Supervisors  Dr Svein Haarvik Pharmacy course director, Bergen 
   Dr David Wright Senior lecturer in pharmacy practice, UEA 
Mr Rick Adams Clinical pharmacist, Norfolk & Norwich University 
Hospital 
 
Guidance for completion 
 
A ‘herbal preparation or medicine’ is defined as any kind of product, such as a tablet, a 
mixture, an ointment or herbal teas, which are produced from plants and used to acquire 
better health. 
• The questionnaire has been designed to take no more than 5-10 minutes to complete 
• The questionnaire does not require your name for completion 
• All responses will be reported anonymously 
• Please tick only one box for each question unless requested to do otherwise 
• Once you have completed the questionnaire, please place it in the prepaid envelope 
provided 
• If you have any questions then please contact Lone Holst on 01603 593144 
Completing and returning the questionnaire constitutes consent to participate in the 
study.    
 
 Version 3  Oct 2007    
 
Section 1 Your awareness and use of herbal preparations/medicines 
This section explores your knowledge and use of herbal preparations.   
1. Have you ever used herbal preparations or medicines in the past? 
Yes             No                 Unsure/don’t remember    
Below is a list of herbal preparations.  For each of the preparations listed below please 
complete the following questions: 
2. Echinaceae (Coneflower) 
Have you heard about the preparation?      Yes                 No     
If ‘No’, go to question 3. 
Have you used it during pregnancy?       Yes                 No     
If ‘No’, go to question 3. 
What condition(s) did you use/take it for? 
 
When during your pregnancy did you use/take it?   Please tick all that apply.    
During 1st 3 months            During 2nd 3 months                      
How long did you use/take it for?  Approximately                 days.        
3. Iron-rich herbs (‘Floradix’) 
Have you heard about the preparation?      Yes                 No     
If ‘No’, go to question 4. 
Have you used it during pregnancy?       Yes                 No     
If ‘No’, go to question 4. 
What condition(s) did you use/take it for? 
 
When during your pregnancy did you use/take it?   Please tick all that apply.    
During 1st 3 months            During 2nd 3 months                      
How long did you use/take it for? Approximately                 days.      
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4. Ginger 
Have you heard about the preparation?      Yes                   No     
If ‘No’, go to question 5. 
Have you used it during pregnancy?       Yes                No     
If ‘No’, go to question 5. 
What condition(s) did you use/take it for? 
 
When during your pregnancy did you use/take it?   Please tick all that apply.    
During 1st 3 months            During 2nd 3 months                      
How long did you use/take it for?  Approximately                 days.        
5. Chamomile 
Have you heard about the preparation?      Yes                 No     
If ‘No’, go to question 6. 
Have you used it during pregnancy?       Yes              No     
If ‘No’, go to question 6. 
What condition(s) did you use/take it for? 
 
When during your pregnancy did you use/take it?   Please tick all that apply.    
During 1st 3 months            During 2nd 3 months                      
How long did you use/take it for?  Approximately                 days.        
6. Valerian 
Have you heard about the preparation?      Yes                 No     
If ‘No’, go to question 7. 
Have you used it during pregnancy?       Yes              No     
If ‘No’, go to question 7. 
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What condition(s) did you use/take it for? 
 
When during your pregnancy did you use/take it?   Please tick all that apply.    
During 1st 3 months            During 2nd 3 months                      
How long did you use/take it for?  Approximately                 days.        
7. Cranberry 
Have you heard about the preparation?     Yes                 No     
If ‘No’, go to question 8. 
Have you used it during pregnancy?       Yes                 No     
If ‘No’, go to question 8. 
What condition(s) did you use/take it for? 
 
When during your pregnancy did you use/take it?   Please tick all that apply.    
During 1st 3 months            During 2nd 3 months                      
How long did you use/take it for?  Approximately                 days.        
8. Horsetail 
Have you heard about the preparation?      Yes                 No     
If ‘No’, go to question 9. 
Have you used it during pregnancy?       Yes              No     
If ‘No’, go to question 9. 
What condition(s) did you use/take it for? 
 
When during your pregnancy did you use/take it?   Please tick all that apply.    
During 1st 3 months            During 2nd 3 months                      
How long did you use/take it for?  Approximately                 days.        
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9. Raspberry Leaf 
Have you heard about the preparation?      Yes              No     
If ‘No’, go to question 10. 
Have you used it during pregnancy?       Yes              No     
If ‘No’, go to question 10. 
What condition(s) did you use/take it for? 
 
When during your pregnancy did you use/take it?   Please tick all that apply.    
During 1st 3 months            During 2nd 3 months                      
How long did you use/take it for?  Approximately                 days.        
10. St John’s Wort 
Have you heard about the preparation?      Yes                 No     
If ‘No’, go to question 11. 
Have you used it during pregnancy?       Yes              No     
If ‘No’, go to question 11. 
What condition(s) did you use/take it for? 
 
When during your pregnancy did you use/take it?   Please tick all that apply.    
During 1st 3 months            During 2nd 3 months                      
How long did you use/take it for?  Approximately                 days.        
11. Did you use any other herbal preparations during pregnancy?  
  Yes        No                Unsure/don’t remember      
If ‘Yes’, please complete the following table. 
 
Product or plant name Condition used for When taken  
(week of pregnancy ) 
Duration of use  
(no. of days) 
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If you have not used herbal preparations during pregnancy, go to question 14.  
12. Who recommended the use of herbal preparations to you?  Please tick all that apply. 
Family or friends    Doctor     
My own idea    Alternative therapist   
Newspaper or magazine   Pharmacist    
Health food store   Nurse or midwife   
Other     Please state:   
13. Did you inform your general practitioner (GP) about your use of herbal preparations 
during pregnancy? 
Yes         No    Unsure/don’t remember   
14. Do you have other children that were breastfed?            Yes     No    
If ‘No’, go to question 15.   
If ‘Yes’, did you use herb tea or other herbal preparations to increase production of breast 
milk? 
Yes        No    Unsure/don’t remember      
15. Do you think you will use herbal preparations in the future? 
Yes        No             Unsure      
16. If you want information about herbal preparations, where or from whom would you seek 
this from?  Please indicate your choices by numbering as many as are applicable to you, 
no. 1 being your first choice. 
Doctor     Health food store    
Alternative therapist   Family or friends   
Pharmacist    Newspaper or magazine  
Nurse or midwife   
Other     Please state:   
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Section 2  Medical conditions experienced during pregnancy and their treatment
This section is to identify what medical conditions you experienced during pregnancy and 
what treatment, if any, you used. 
During your pregnancy, did you experience:  
17. Nausea, vomiting or morning sickness?    
Yes    No    Unsure/don’t remember      
If ‘Yes’, please complete the following, otherwise go to question 18. 
 
When did you experience it?  Please tick all that apply. 
During 1st 3 months             During 2nd 3 months                     
Please state how you treated it in the box below:  
 
 
 
 
 
18. Fatigue?  Yes     No                Unsure/don’t remember      
If ‘Yes’, please complete the following, otherwise go to question 19. 
When did you experience it?  Please tick all that apply. 
During 1st 3 months             During 2nd 3 months                     
Please state how you treated it in the box below:  
 
 
 
 
 
     
19. Indigestion or heartburn? Yes     No                Unsure/don’t remember      
If ‘Yes’, please complete the following, otherwise go to question 20. 
When did you experience it?  Please tick all that apply. 
During 1st 3 months             During 2nd 3 months                     
Please state how you treated it in the box below:  
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20. Common Cold?  Yes      No      Unsure/don’t remember      
If ‘Yes’, please complete the following, otherwise go to question 21. 
When did you experience it?  Please tick all that apply. 
During 1st 3 months             During 2nd 3 months                     
Please state how you treated it in the box below:  
 
 
 
 
 
     
21. Urinary Tract Infection?   Yes     No                Unsure/don’t remember      
If ‘Yes’, please complete the following, otherwise go to question 22. 
When did you experience it?  Please tick all that apply. 
During 1st 3 months             During 2nd 3 months                     
Please state how you treated it in the box below:  
 
 
 
 
 
     
 
22. Swollen ankles?    Yes               No                Unsure/don’t remember      
If ‘Yes’, please complete the following, otherwise go to question 23. 
When did you experience it?  Please tick all that apply. 
During 1st 3 months             During 2nd 3 months                     
Please state how you treated it in the box below:  
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23. Have you experienced any other conditions during pregnancy? 
If ‘Yes’, please complete the following table to indicate what other condition(s) you 
experienced and when, and how you treated it/them, otherwise go to question 24. 
                 Yes        No                Unsure/don’t remember      
Condition Week of 
pregnancy 
Treatment 
   
   
   
   
 
 
Section 3  Your opinions about medicines in general 
 
Below are some statements about medicines in general (not only herbal medicines). Please 
indicate the extent to which you agree or disagree with them by ticking the box which most 
closely reflects your opinion.   
24. Medicines do more harm than good 
Strongly agree   Agree   Uncertain     Disagree     Strongly disagree  
25. Natural remedies are safer than medicines 
Strongly agree   Agree   Uncertain     Disagree     Strongly disagree  
26. If doctors had more time with patients they would prescribe fewer medicines 
Strongly agree   Agree   Uncertain     Disagree     Strongly disagree  
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Section 4  Personal Details 
Please complete the following information: 
27. Your year of birth: 
28. Number of pregnancies before this one: 
29. Marital status:     Married/cohabitant      Single         Other   
30. Did you smoke during pregnancy?   Not at all          Now and then  Daily   
31. Do you take any medicines regularly?                 
   Yes             No    
If yes, please complete the following table to indicate which medicine(s) you take and for 
what condition(s).  
Medicine Condition(s) taken for 
  
  
  
  
  
  
32. When did you finish your education?   
After completing: GCSEs/’O’ levels   
   ‘A’ levels    
University degree   
Other     Please state: 
33. What is your occupation?  If you are a housewife and have a partner, please give your 
partner’s occupation.   
 
34. Do you pay for your prescription medicines?      
   Yes             No      
 
 
Thank you for taking the time to complete this questionnaire.  
  
 
